Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts.

BACKGROUND Although interferon (IFN)gamma has immunostimulatory functions, it is not essential for the acute rejection of fully allogeneic grafts in mice. It is not known whether IFNgamma plays a critical role in the acute rejection of MHC class I- or MHC class II-disparate allografts. METHODS We studied the survival of skin allografts transplanted from fully allogeneic (BALB/c), MHC class I-disparate (bml), or MHC class II-disparate (bm12) donors to C57BL/6 wild-type (IFNgamma+/+) and IFNgamma gene-knockout (IFNgamma-/-) recipients. We also investigated the in vitro responses of IFNgamma+/+ and IFNgamma-/- T cells to MHC class II-disparate splenocytes. RESULTS We found that IFNgamma-/- recipients reject BALB/c and bml skin grafts at the same rate as IFNgamma+/+ mice but are not capable of rejecting bm12 skin. Despite the inability of IFNgamma-/- mice to reject bm12 skin grafts, IFNgamma-/- T cells displayed vigorous proliferation and cytotoxic responses when stimulated with bm12 splenocytes in vitro. Furthermore, priming IFNgamma-/- recipients with bm12 splenocytes enabled these mice to reject bm12 skin grafts at a normal rate and to mount a cutaneous delayed-type hypersensitivity response to the bm12 antigen. CONCLUSION The data demonstrate that IFNgamma is not necessary for generating effector mechanisms associated with acute transplant rejection but that it is required for initiating alloimmune responses to MHC class II-disparate skin grafts.

[1]  A. Billiau,et al.  Interferon-gamma: biology and role in pathogenesis. , 1996, Advances in immunology.

[2]  A. Gaspari,et al.  Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. , 1988, Journal of immunology.

[3]  P. Linsley,et al.  IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. , 1998, Journal of immunology.

[4]  D. Schmitt,et al.  Dissection of human Langerhans cells' allostimulatory function: The need for an activation step for full development of accessory function , 1993, European journal of immunology.

[5]  A. Bradley,et al.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.

[6]  A. Minty,et al.  Interleukin 13 is a B cell stimulating factor , 1994, The Journal of experimental medicine.

[7]  P. Nickerson,et al.  Interferon-gamma receptor signaling is not required in the effector phase of the alloimmune response. , 1998, Transplantation.

[8]  J. Sprent,et al.  Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences , 1986, The Journal of experimental medicine.

[9]  Fadi G Lakkis,et al.  Acute rejection of vascularized heart allografts in the absence of IFNgamma. , 1996, Transplantation.

[10]  P. Halloran,et al.  The unique role of interferon-gamma in the regulation of MHC expression on arterial endothelium. , 1996, Transplantation.

[11]  R. Steinman,et al.  Migration and maturation of Langerhans cells in skin transplants and explants , 1990, The Journal of experimental medicine.

[12]  M. Dallman,et al.  Induction of Ia antigens on murine epidermal cells during the rejection of skin allografts. , 1983, Transplantation.

[13]  A. Singer,et al.  Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody. , 1990, Journal of immunology.

[14]  A. Singer,et al.  Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells. , 1989, Journal of immunology.